Since
its approval in May 2006, many people have turned to Chantix to stop smoking.
While the medication was initially presented as one with very few side effects,
Chantix has since been associated with numerous reports of suicides and other
potentially serious injuries caused by unusual Chantix mood swings and behavior while taking the drug.
Pfizer, the drug’s maker, failed to warn consumers about these psychological
side effects of Chantix, and lawsuits are being reviewed nationwide on behalf
of users who suffered a serious physical injury or death as a result of suicide.
Experts say that
people suffering from depression and mental problems are more likely to smoke
and
Tuesday, October 25, 2011
Friday, October 21, 2011
Cases Build for Chantix Suicides and Suicide Attempts, FDA Ups Warning
Shortly after Chantix was introduced, an alarming number of reports were received by the FDA MedWatch adverse event reporting system involving users who committed suicide on Chantix or suddenly attempted suicide, despite no prior history of psychological problems. In November 2007, the FDA issued an early communication regarding an emerging safety concern which linked the use of Chantix and suicide, suicidal thoughts and sudden changes in behavior. In February 2008, the FDA issued a statement which suggested that their evaluation indicates it is “increasingly likely that there may be an association between Chantix and serious neuropsychiatric symptoms.” In July 2009, the FDA required Pfizer to add a prominently displayed boxed warning stating the possible side effects of Chantix including behavior changes, depression, hostility and suicidal thoughts, which is the
Thursday, October 13, 2011
Heart Attacks Just Now Understood As Chantix Side Effect
Last month, the FDA did take some action on risks associated with Chantix cardiovascular problems by warning
that people with pre-existing heart problems could face a higher risk of
cardiovascular events if they take the drug. The information, which was added
to the “Warnings and Precautions” section of the Chantix label, was based on a
study that assessed Chantix for smoking cessation in 700 patients aged 35 to 75
years with stable, documented cardiovascular disease. Chantix was approved in the United States by the FDA in 2006 as a
prescription medication to help people quit smoking. The drug works by reducing
the positive feelings that come from cigarettes, blocking the receptors in the
brain commonly stimulated by nicotine. However, the impact of the drug on the
brain has resulted in a number of reports from users who experienced sudden,
unusually aggressive behavior, thoughts of self-harm and extreme cases, Chantix suicide.
Wednesday, October 12, 2011
Chantix Suicide Most Critical Side Effect of Quit Smoking Drug
In
2008 The FDA announced a public health advisory about
abnormal behavior, agitation, Chantix depression, suicidal ideation, and actual
suicidal behavior with Pfizer’s anti-smoking drug. The FDA provided updated
numbers - 491 cases of suicidal thinking or behavior, including 420 in the US
and of those, there were 39 suicides, including 34 in the US. Many of the cases were reported for patients
without any prior history of psychiatric illness. Government scientists
are conducting further investigating into the drug and, specifically, the
reports of Chantix suicide and suicidal ideation. Chantix, approved in 2006, works
by blocking nicotine receptors to the brain. Chantix is the first such nicotine
receptor partial agonist approved by the FDA. It was heralded as an alternative
to other smoking cessation drugs and nicotine replacement therapy.
Tuesday, October 11, 2011
Chantix Heart Attack Evidence Mounting
Many users of the popular smoking cessation drug are familiar with the adverse Chantix side effects that have been linked to the drug, including psychological conditions
and cardiovascular problems. These risks include suicidal thoughts, suicide,
increased rage or aggression, depression, and mood swings as well as Chantix heart attack, vascular disease, angina pectoris, and coronary revascularization.
These problems, particularly the ones related to heart problems, can also
manifest in smokers because of the smoking itself, making filing lawsuits
regarding Chantix heart problems a little more tricky than they might otherwise
be.
Wednesday, October 5, 2011
Chantix Multidistrict Litigation Inching Forward
Although Chantix litigation has been consolidated in
multidistrict litigation, as presided over by District Judge Inge P. Johnson,
since October of 2009, many plaintiffs and other interested parties are unaware
of the progress it has been making since it was consolidated. At the time of the
consolidation, which was requested in July of 2009, there were only 34 Chantix lawsuits involved. Now, there are more than 1,200 that have been filed in courts
across the country and are being consolidated in multidistrict litigation,
which will combine pretrial processes in similar cases in order to expedite the
legal process.
Most
Chantix cases involved in multidistrict litigation are related to Chantix suicide and suicide attempts, which is one of the more common psychological
side effects of the popular smoking cessation aid. However, there are a
multitude of other Chantix side effects listed as
Tuesday, October 4, 2011
Chantix Lawsuit Settlements Gauged by Bellwether Trials
Although Chantix lawsuits are still coming in from across
the country, thousands of lawsuits that have already been combined in Chantix
multidistrict litigation are preparing for trials in the coming years. These
cases, largely dealing with Chantix-related psychological problems like
anxiety, depression, and Chantix suicide have been consolidated in a process that will
speed litigation and help plaintiffs reach a settlement more quickly, as pretrial
processes in similar cases are combined.
Chantix
psychological problems are a highly-publicized phenomenon which seems to
develop mostly in patients with a personal or family history of psychological
disorders or behavioral and emotional problems. These same people were
deliberately left out of Chantix clinical trials by drugmaker Pfizer, despite
the fact that statistically, people with psychological problems are much more
likely to be smokers than people without these conditions. Suicidal thoughts and
suicide attempts are not uncommon Chantix side effects, and some
Subscribe to:
Posts (Atom)